Cargando…
SAT-346 Hypercalcemia Secondary to Calcitriol and PTHrP Cosecretion Only Responsive to Hydroxychloroquine
Background: Hypercalcemia of malignancy mediated by concurrent elevations in both 1,25-dihydroxyvitamin D (calcitriol) and parathyroid hormone (PTH)-related protein (PTHrP) is a rare phenomenon previously only reported with solid tumors. The preferred treatment for calcitriol-mediated hypercalcemia...
Autores principales: | Panvelker, Samir S, Khan, Amna Nabeel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209582/ http://dx.doi.org/10.1210/jendso/bvaa046.685 |
Ejemplares similares
-
SAT-LB63 A Case of PTHrP-Negative Hypercalcemia of Malignancy
por: Murati, Jonila, et al.
Publicado: (2020) -
SAT-493 A Case of Endometrial Adenocarcinoma Presenting with PTHrP-Mediated Hypercalcemia
por: Weaver, Anne, et al.
Publicado: (2019) -
SAT-498 Use of Cinacalcet for PTHrP-Mediated Hypercalcemia of Malignancy in Penile Squamous Cell Carcinoma
por: Pulipati, Vishnu Priya, et al.
Publicado: (2019) -
SAT-502 Bisphosphonates for Treatment of Calcitriol-Induced Hypercalcemia
por: Mateo, Roselyn Cristelle, et al.
Publicado: (2019) -
Prednisone-Responsive Hypercalcemia in a Patient With IgG4 Disease and Elevated Serum PTHrP Levels
por: Cohen, Melissa, et al.
Publicado: (2021)